| Early remdesivir to prevent progression to severe Covid-19 in outpatients RL Gottlieb, CE Vaca, R Paredes, J Mera, BJ Webb, G Perez, G Oguchi, ... New England Journal of Medicine 386 (4), 305-315, 2022 | 1184 | 2022 |
| Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain J Berenguer, P Ryan, J Rodriguez-Bano, I Jarrín, J Carratala, J Pachon, ... Clinical Microbiology and Infection 26 (11), 1525-1536, 2020 | 362 | 2020 |
| Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, ... The Lancet 399 (10339), 1941-1953, 2022 | 252 | 2022 |
| Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19 JF Bermejo-Martin, M González-Rivera, R Almansa, D Micheloud, ... Critical Care 24, 1-13, 2020 | 227 | 2020 |
| Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos (t) ide reverse … JR Arribas, PM Girard, R Landman, J Pich, J Mallolas, ... The Lancet Infectious Diseases 15 (7), 785-792, 2015 | 193 | 2015 |
| Sexualized drug use (Chemsex) is associated with high-risk sexual behaviors and sexually transmitted infections in HIV-positive men who have sex with men: data from the U-SEX … A González-Baeza, H Dolengevich-Segal, I Pérez-Valero, A Cabello, ... AIDS Patient Care and STDs 32 (3), 112-118, 2018 | 143 | 2018 |
| Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19) J Rodríguez-Baño, J Pachón, J Carratala, P Ryan, I Jarrín, M Yllescas, ... Clinical Microbiology and Infection 27 (2), 244-252, 2021 | 140 | 2021 |
| Dual therapy with darunavir and ritonavir plus lamivudine vs triple therapy with darunavir and ritonavir plus tenofovir disoproxil fumarate and emtricitabine or abacavir and … F Pulido, E Ribera, M Lagarde, I Pérez-Valero, R Palacios, JA Iribarren, ... Clinical Infectious Diseases 65 (12), 2112-2118, 2017 | 130* | 2017 |
| Neutralizing autoantibodies to type I IFNs in> 10% of patients with severe COVID-19 pneumonia hospitalized in Madrid, Spain J Troya, P Bastard, L Planas-Serra, P Ryan, M Ruiz, M de Carranza, ... Journal of clinical immunology 41, 914-922, 2021 | 121 | 2021 |
| Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients D De Gonzalo-Calvo, ID Benitez, L Pinilla, A Carratala, A Moncusi-Moix, ... Translational research 236, 147-159, 2021 | 109 | 2021 |
| Risk factors for advanced liver fibrosis in HIV‐infected individuals: role of antiretroviral drugs and insulin resistance F Blanco, P Barreiro, P Ryan, E Vispo, L Martín‐Carbonero, P Tuma, ... Journal of viral hepatitis 18 (1), 11-16, 2011 | 95 | 2011 |
| Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score J Berenguer, AM Borobia, P Ryan, J Rodríguez-Baño, JM Bellón, I Jarrín, ... Thorax 76 (9), 920-929, 2021 | 94 | 2021 |
| Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study B Gutiérrez-Gutiérrez, MD Del Toro, AM Borobia, A Carcas, I Jarrín, ... The Lancet infectious diseases 21 (6), 783-792, 2021 | 80 | 2021 |
| Characteristics, complications and outcomes among 1549 patients hospitalised with COVID-19 in a secondary hospital in Madrid, Spain: a retrospective case series study E Jimenez, M Fontan-Vela, J Valencia, I Fernandez-Jimenez, ... BMJ open 10 (11), e042398, 2020 | 80 | 2020 |
| GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 E Pairo-Castineira, K Rawlik, AD Bretherick, T Qi, Y Wu, I Nassiri, ... Nature 617 (7962), 764-768, 2023 | 67 | 2023 |
| All‐oral direct‐acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real‐world practice: Madrid coinfection … J Berenguer, Á Gil‐Martin, I Jarrin, A Moreno, L Dominguez, M Montes, ... Hepatology 68 (1), 32-47, 2018 | 66 | 2018 |
| Drug-related and psychopathological symptoms in HIV-positive men who have sex with men who inject drugs during sex (slamsex): Data from the U-SEX GESIDA 9416 Study H Dolengevich-Segal, A Gonzalez-Baeza, J Valencia, E Valencia-Ortega, ... PLoS One 14 (12), e0220272, 2019 | 60 | 2019 |
| Plasma miRNA profile at COVID-19 onset predicts severity status and mortality A Fernández-Pato, A Virseda-Berdices, S Resino, P Ryan, ... Emerging microbes & infections 11 (1), 676-688, 2022 | 53 | 2022 |
| Novel genes and sex differences in COVID-19 severity R Cruz, S Diz-de Almeida, M López de Heredia, I Quintela, FC Ceballos, ... Human Molecular Genetics 31 (22), 3789-3806, 2022 | 53 | 2022 |
| Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia C Rueda, M Puig-Asensio, J Guinea, B Almirante, M Cuenca-Estrella, ... Clinical Microbiology and Infection 23 (1), 49. e1-49. e8, 2017 | 48 | 2017 |
Salvador ResinoHead of laboratory (Centro Nacional de Microbiología - Instituto de Salud Carlos III)在 isciii.es 的电子邮件经过验证
